The involvement of astrocytes and kynurenine pathway in Alzheimer's disease

被引:40
|
作者
Ting, Ka Ka [1 ,3 ]
Brew, Bruce [2 ]
Guillemin, Gilles [1 ,3 ]
机构
[1] St Vincents Hosp, Ctr Immunol, Sydney, NSW 2010, Australia
[2] St Vincents Hosp, Dept Neurol, Sydney, NSW 2010, Australia
[3] Univ New S Wales, Dept Pharmacol, Sydney, NSW 2052, Australia
基金
英国医学研究理事会;
关键词
astrocyte; kynurenine pathway; Alzheimer's disease; neuroinflammation;
D O I
10.1007/BF03033908
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The kynurenine pathway (KP) and several of its neuroactive products, especially quinolinic acid (QUIN), are considered to be involved in the neuropathogenesis of Alzheimer's disease (AD). There is growing evidence suggesting that astrocytes play a critical role in the regulation of the excitotoxicity and inflammatory processes that occur during the evolution of AD. This review focuses on the role of astrocytes through their relation with the KP to the different features associated with AD including cytokine, chemokine and, adhesion molecule production, cytoskeletal changes, astrogliosis, excitotoxicity, apoptosis and neurodegeneration.
引用
收藏
页码:247 / 262
页数:16
相关论文
共 50 条
  • [31] Astrocytes as a Biomarker of Alzheimer's Disease?
    Wagner, Annkatrin
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2021, 89 (12) : 600 - 602
  • [32] ALZHEIMER'S DISEASE AND SEIZURES: INTERLEUKIN-18, KYNURENINE PATHWAY AND QUINOLINIC ACID PRODUCTION
    Ojala, J. O.
    Sutinen, E. M.
    Myint, A. M.
    Pirttila, T.
    Soininen, H.
    Anderson, G.
    JOURNAL OF NEUROCHEMISTRY, 2011, 118 : 131 - 131
  • [33] Inflammation, negative affect, and amyloid burden in Alzheimer's disease: Insights from the kynurenine pathway
    Willette, Auriel A.
    Pappas, Colleen
    Hoth, Nathan
    Wang, Qian
    Klinedinst, Brandon
    Willette, Sara A.
    Larsen, Brittany
    Pollpeter, Amy
    Li, Tianqi
    Le, Scott
    Collazo-Martinez, Ana D.
    Mochel, Jonathan P.
    Allenspach, Karin
    Dantzer, Robert
    BRAIN BEHAVIOR AND IMMUNITY, 2021, 95 : 216 - 225
  • [34] Targeting the Kynurenine Pathway-Related Alterations in Alzheimer's Disease: A Future Therapeutic Strategy
    Plangar, Imola
    Zadori, Denes
    Klivenyi, Peter
    Toldi, Jozsef
    Vecsei, Laszlo
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 24 : 199 - 209
  • [35] The Tryptophan Catabolite or Kynurenine Pathway in Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Almulla, Abbas F.
    Supasitthumrong, Thitiporn
    Amrapala, Arisara
    Tunvirachaisakul, Chavit
    Jaleel, Al-Karrar Kais Abdul
    Oxenkrug, Gregory
    Al-Hakeim, Hussein K.
    Maes, Michael
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 88 (04) : 1325 - 1339
  • [36] Kynurenine and its metabolites in Alzheimer's disease patients
    Gulaj, E.
    Pawlak, K.
    Bien, B.
    Pawlak, D.
    ADVANCES IN MEDICAL SCIENCES, 2010, 55 (02): : 204 - 211
  • [37] Involvement of Kynurenine Pathway in Hepatocellular Carcinoma
    Krishnamurthy, Shivani
    Gilot, David
    Ahn, Seong Beom
    Lam, Vincent
    Shin, Joo-Shik
    Guillemin, Gilles Jackie
    Heng, Benjamin
    CANCERS, 2021, 13 (20)
  • [38] The Involvement of Kynurenine Pathway in Neurodegenerative Diseases
    Martins, Lais B.
    Silveira, Ana L. M.
    Teixeira, Antonio L.
    CURRENT NEUROPHARMACOLOGY, 2023, 21 (02) : 260 - 272
  • [39] All roads lead to heterogeneity: The complex involvement of astrocytes and microglia in the pathogenesis of Alzheimer's disease
    St-Pierre, Marie-Kim
    VanderZwaag, Jared
    Loewen, Sophia
    Tremblay, Marie-Eve
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2022, 16
  • [40] Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis
    Fathi, Mobina
    Vakili, Kimia
    Yaghoobpoor, Shirin
    Tavasol, Arian
    Jazi, Kimia
    Hajibeygi, Ramtin
    Shool, Sina
    Sodeifian, Fatemeh
    Klegeris, Andis
    McElhinney, Alyssa
    Tavirani, Mostafa Rezaei
    Sayehmiri, Fatemeh
    FRONTIERS IN IMMUNOLOGY, 2022, 13